BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gibbons TE, Gold BD. The use of proton pump inhibitors in children: a comprehensive review. Paediatr Drugs 2003;5:25-40. [PMID: 12513104 DOI: 10.2165/00128072-200305010-00003] [Cited by in Crossref: 69] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Friedrichsdorf SJ, Drake R, Webster ML. Gastrointestinal Symptoms. Textbook of Interdisciplinary Pediatric Palliative Care. Elsevier; 2011. pp. 311-34. [DOI: 10.1016/b978-1-4377-0262-0.00033-5] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
2 Solana MJ, López-Herce J, Botrán M, Urbano J, Del Castillo J, Garrido B. [Hemodynamic effects of intravenous omeprazole in critically ill children]. An Pediatr (Barc) 2013;78:167-72. [PMID: 22818224 DOI: 10.1016/j.anpedi.2012.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Kakiuchi T, Matsuo M, Endo H, Nakayama A, Sato K, Takamori A, Sasaki K, Takasaki M, Hara M, Sakata Y, Okuda M, Kikuchi S, Eguchi Y, Takahashi H, Anzai K, Fujimoto K. A Helicobacter pylori screening and treatment program to eliminate gastric cancer among junior high school students in Saga Prefecture: a preliminary report. J Gastroenterol 2019;54:699-707. [DOI: 10.1007/s00535-019-01559-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
4 Colombo JL, Thomas HM. Aspiration Syndromes. Pediatric Respiratory Medicine. Elsevier; 2008. pp. 337-45. [DOI: 10.1016/b978-032304048-8.50029-3] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
5 Carcelén Andrés J, Barroso Pérez C, Fábrega Bosacoma C, Feal Cortizas B, Gallego Lago V, Hidalgo Albert E, Pozas del Río M, Revert Molina-niñirola A, Valverde Molina E, Wood Wood M. Inhibidores de la bomba de protones en pediatría. Farmacia Hospitalaria 2005;29:43-54. [DOI: 10.1016/s1130-6343(05)73635-7] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Størdal K, Johannesdottir GB, Bentsen BS, Knudsen PK, Carlsen KC, Closs O, Handeland M, Holm HK, Sandvik L. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease. Arch Dis Child 2005;90:956-60. [PMID: 16113133 DOI: 10.1136/adc.2004.068890] [Cited by in Crossref: 79] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
7 Goldman CG, Barrado DA, Balcarce N, Rua EC, Oshiro M, Calcagno ML, Janjetic M, Fuda J, Weill R, Salgueiro MJ. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition. 2006;22:984-988. [PMID: 16978844 DOI: 10.1016/j.nut.2006.06.008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
8 El Rouby N, Lima JJ, Johnson JA. Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine. Expert Opin Drug Metab Toxicol. 2018;14:447-460. [PMID: 29620484 DOI: 10.1080/17425255.2018.1461835] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
9 Kwong K, Hoa M, Coticchia JM. Recurrent croup presentation, diagnosis, and management. Am J Otolaryngol 2007;28:401-7. [PMID: 17980773 DOI: 10.1016/j.amjoto.2006.11.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
10 Shakhnovich V, Smith PB, Guptill JT, James LP, Collier DN, Wu H, Livingston CE, Zhao J, Kearns GL; Best Pharmaceuticals for Children Act – Pediatric Trials Network. Obese Children Require Lower Doses of Pantoprazole Than Nonobese Peers to Achieve Equal Systemic Drug Exposures. J Pediatr 2018;193:102-108.e1. [PMID: 29389444 DOI: 10.1016/j.jpeds.2017.10.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
11 Mansell P, Robinson K, Minck D, Hurtt ME, Cappon GD. Toxicology and toxicokinetics of oral pantoprazole in neonatal and juvenile dogs. Birth Defects Res B Dev Reprod Toxicol 2011;92:345-52. [PMID: 21818842 DOI: 10.1002/bdrb.20325] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Rosas-Blum E, Tatevian N, Hashmi SS, Rhoads JM, Navarro F. Non-Specific Gastric Inflammation in Children is Associated with Proton Pump Inhibitor Treatment for More than 6 Weeks. Front Pediatr 2014;2:3. [PMID: 24479108 DOI: 10.3389/fped.2014.00003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Solana MJ, López-Herce J. Pharmacokinetics of intravenous omeprazole in critically ill paediatric patients. Eur J Clin Pharmacol 2010;66:323-30. [PMID: 20041322 DOI: 10.1007/s00228-009-0774-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
14 Ward RM, Kearns GL. Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics. Paediatr Drugs. 2013;15:119-131. [PMID: 23512128 DOI: 10.1007/s40272-013-0012-x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 71] [Article Influence: 9.0] [Reference Citation Analysis]
15 Hegar B, Hutapea EI, Advani N, Vandenplas Y. A double-blind placebo-controlled randomized trial on probiotics in small bowel bacterial overgrowth in children treated with omeprazole. J Pediatr (Rio J). 2013;89:381-387. [PMID: 23796359 DOI: 10.1016/j.jped.2012.12.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
16 Michaud L, Guimber D, Blain-stregloff A, Ganga-zandzou S, Gottrand F, Turck D. Longevity of Balloon-stabalized Skin-level Gastrostomy Devive: . Journal of Pediatric Gastroenterology and Nutrition 2004;38:426-9. [DOI: 10.1097/00005176-200404000-00011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tovar JA, Luis AL, Encinas JL, Burgos L, Pederiva F, Martinez L, Olivares P. Pediatric surgeons and gastroesophageal reflux. Journal of Pediatric Surgery 2007;42:277-83. [DOI: 10.1016/j.jpedsurg.2006.10.025] [Cited by in Crossref: 41] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
18 Gold BD. Asthma and gastroesophageal reflux disease in children: exploring the relationship. J Pediatr. 2005;146:S13-S20. [PMID: 15758898 DOI: 10.1016/j.jpeds.2004.11.036] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
19 Shakhnovich V, Ward RM, Kearns GL. Failure of proton pump inhibitors to treat GERD in neonates and infants: a question of drug, diagnosis, or design. Clin Pharmacol Ther. 2012;92:388-392. [PMID: 22805424 DOI: 10.1038/clpt.2012.86] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
20 Durvasula VS, O’neill AC, Richter GT. Oropharyngeal Dysphagia in Children. Otolaryngologic Clinics of North America 2014;47:691-720. [DOI: 10.1016/j.otc.2014.06.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
21 Zimmerman KO, Smith PB, McMahon AW, Temeck J, Avant D, Murphy D, McCune S. Duration of Pediatric Clinical Trials Submitted to the US Food and Drug Administration. JAMA Pediatr 2019;173:60-7. [PMID: 30452504 DOI: 10.1001/jamapediatrics.2018.3227] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
22 Mullin JM, Gabello M, Murray LJ, Farrell CP, Bellows J, Wolov KR, Kearney KR, Rudolph D, Thornton JJ. Proton pump inhibitors: actions and reactions. Drug Discov Today. 2009;14:647-660. [PMID: 19443264 DOI: 10.1016/j.drudis.2009.03.014] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
23 Gremse DA, Donnelly JR, Kukulka MJ, Lloyd E, Lee C. A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet in water via oral syringe: A NOVEL OPTION FOR DOSING LANSOPRAZOLE ORALLY DISINTEGRATING TABLETS. Alimentary Pharmacology & Therapeutics 2004;19:1211-5. [DOI: 10.1111/j.1365-2036.2004.01940.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
24 Zoizner-Agar G, Rotsides JM, Shao Q, Rickert S, Ward R, Greifer M, April M. Proton pump inhibitor administration in neonates and infants. Lack of consensus - An ASPO survey. Int J Pediatr Otorhinolaryngol 2020;137:110200. [PMID: 32679431 DOI: 10.1016/j.ijporl.2020.110200] [Reference Citation Analysis]
25 Trivić A, Cevik M, Folić M, Krejovic-Trivić S, Rubino S, Micić J, Stevanović G, Milovanović J, Jotić A, Barać A. Management of Orbital Complications of Acute Rhinosinusitis in Pediatric Patients: A 15-Year Single-Center Experience. Pediatr Infect Dis J 2019;38:994-8. [PMID: 31306351 DOI: 10.1097/INF.0000000000002414] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Bestebreurtje P, Roeleveld N, Knibbe CAJ, van Sorge AA, Plötz FB, de Wildt SN. Development and Stability Study of an Omeprazole Suppository for Infants. Eur J Drug Metab Pharmacokinet 2020;45:627-33. [PMID: 32594306 DOI: 10.1007/s13318-020-00629-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Kierkus J, Oracz G, Korczowski B, Szymanska E, Wiernicka A, Woynarowski M. Comparative Safety and Efficacy of Proton Pump Inhibitors in Paediatric Gastroesophageal Reflux Disease. Drug Saf 2014;37:309-16. [DOI: 10.1007/s40264-014-0154-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Tolia V, Bishop PR, Tsou VM, Gremse D, Soffer EF, Comer GM. Multicenter, Randomized, Double-Blind Study Comparing 10, 20 and 40 mg Pantoprazole in Children (5-11 Years) With Symptomatic Gastroesophageal Reflux Disease. Journal of Pediatric Gastroenterology & Nutrition 2006;42:384-91. [DOI: 10.1097/01.mpg.0000214160.37574.d3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
29 Indrio F, Riezzo G, Raimondi F, Cavallo L, Francavilla R. Regurgitation in healthy and non healthy infants. Ital J Pediatr 2009;35:39. [PMID: 20003194 DOI: 10.1186/1824-7288-35-39] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
30 Kimko H, Thyssen A, Mould DR, Mannaert E, Treem WR. Helicobacter pylori treatment in children: Defining a dose for rabeprazole as a part of a triple therapy regimen. The Journal of Clinical Pharmacology 2015;55:592-600. [DOI: 10.1002/jcph.457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
31 Bestebreurtje P, de Koning BAE, Roeleveld N, Knibbe CAJ, Tibboel D, van Groen B, van de Ven CP, Plötz FB, de Wildt SN. Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial. Eur J Drug Metab Pharmacokinet 2020;45:635-43. [PMID: 32594305 DOI: 10.1007/s13318-020-00630-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Litalien C, Théorêt Y, Faure C. Pharmacokinetics of proton pump inhibitors in children. Clin Pharmacokinet 2005;44:441-66. [PMID: 15871633 DOI: 10.2165/00003088-200544050-00001] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 4.4] [Reference Citation Analysis]
33 Shakhnovich V, Brian Smith P, Guptill JT, James LP, Collier DN, Wu H, Livingston CE, Zhao J, Kearns GL, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act–Pediatric Trials Network. A Population-Based Pharmacokinetic Model Approach to Pantoprazole Dosing for Obese Children and Adolescents. Paediatr Drugs 2018;20:483-95. [PMID: 30097906 DOI: 10.1007/s40272-018-0305-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
34 Novembre E, Mori F, Pucci N, Bernardini R, Vierucci A, Martino MD. Systemic treatment of rhinosinusitis in children. Pediatr Allergy Immunol 2007;18:56-61. [DOI: 10.1111/j.1399-3038.2007.00636.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
35 Bernal CJ, Aka I, Carroll RJ, Coco JR, Lima JJ, Acra SA, Roden DM, Van Driest SL. CYP2C19 Phenotype and Risk of Proton Pump Inhibitor-Associated Infections. Pediatrics 2019;144:e20190857. [PMID: 31699831 DOI: 10.1542/peds.2019-0857] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
36 Solana García MJ, López-Herce Cid J, Sánchez Sánchez C. Gastroesophageal reflux in critically ill children: a review. ISRN Gastroenterol 2013;2013:824320. [PMID: 23431462 DOI: 10.1155/2013/824320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
37 Croxtall JD, Perry CM, Keating GM. Esomeprazole: In Gastroesophageal Reflux Disease in Children and Adolescents. Pediatric Drugs 2008;10:199-205. [DOI: 10.2165/00148581-200810030-00008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
38 Tang Girdwood SC, Rossow KM, Van Driest SL, Ramsey LB. Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians. Pediatr Res 2021. [PMID: 33824446 DOI: 10.1038/s41390-021-01499-2] [Reference Citation Analysis]
39 Moreira Dias L. Pantoprazole: a proton pump inhibitor. Clin Drug Investig 2009;29 Suppl 2:3-12. [PMID: 19938880 DOI: 10.2165/1153121-S0-000000000-00000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kato S, Shimizu T, Toyoda S, Gold BD, Ida S, Ishige T, Fujimura S, Kamiya S, Konno M, Kuwabara K, Ushijima K, Yoshimura N, Nakayama Y; Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition. The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood. Pediatr Int 2020;62:1315-31. [PMID: 32657507 DOI: 10.1111/ped.14388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Martín de Argila C. Safety of potent gastric acid inhibition. Drugs 2005;65 Suppl 1:97-104. [PMID: 16335863 DOI: 10.2165/00003495-200565001-00013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
42 Esplugues JV, Martí-Cabrera M, Ponce J. [Safety of proton pump inhibitors]. Med Clin (Barc) 2006;127:790-5. [PMID: 17198667 DOI: 10.1157/13095825] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
43 Gold BD. Gastroesophageal reflux disease: could intervention in childhood reduce the risk of later complications? Am J Med 2004;117 Suppl 5A:23S-9S. [PMID: 15478849 DOI: 10.1016/j.amjmed.2004.07.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
44 Tighe MP, Afzal NA, Bevan A, Beattie RM. Current Pharmacological Management of Gastro-Esophageal Reflux in Children: An Evidence-Based Systematic Review. Pediatric Drugs 2009;11:185-202. [DOI: 10.2165/00148581-200911030-00004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
45 Orel R, Benninga MA, Broekaert IJ, Gottrand F, Papadopoulou A, Ribes-Koninckx C, Thomson M, Wilschanski M, Thapar N. Drugs in Focus: Proton Pump Inhibitors. J Pediatr Gastroenterol Nutr 2021;72:645-53. [PMID: 33847286 DOI: 10.1097/MPG.0000000000003063] [Reference Citation Analysis]
46 Marchisio P, Ghisalberti E, Fusi M, Baggi E, Ragazzi M, Dusi E. Paranasal sinuses and middle ear infections: what do they have in common? Pediatr Allergy Immunol 2007;18 Suppl 18:31-4. [PMID: 17767605 DOI: 10.1111/j.1399-3038.2007.00630.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
47 Diaz DM, Winter HS, Colletti RB, Ferry GD, Rudolph CD, Czinn SJ, Cochran W, Gold BD; NASPGHAN/CDHNF Scientific Advisory Board. Knowledge, attitudes and practice styles of North American pediatricians regarding gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2007;45:56-64. [PMID: 17592365 DOI: 10.1097/MPG.0b013e318054b0dd] [Cited by in Crossref: 35] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]